Loading organizations...
Loading organizations...
Embryo Ventures is a global early-stage venture capital firm, specializing in pre-seed and seed investments. The firm supports startups developing transformative technologies across Human Health and Human Experience. This includes innovations that restore, sustain, and expand human potential, alongside essential systems shaping daily life, such as connectivity, mobility, and care.
Founded in 2019, Embryo Ventures operates on a core belief in the "Power of Beginnings," recognizing the critical juncture where new ventures emerge. The firm partners with exceptional founders at this nascent stage, driven by an insight to redefine fundamental human experiences. This approach guides its investment strategy for ambitious endeavors.
The firm primarily targets visionary founders of early-stage companies innovating within health and experience sectors. Embryo Ventures empowers these founders, championing ventures that drive meaningful, long-term societal change. It envisions a future profoundly shaped by technology and ingenuity, fostering advancements that redefine the lived experience.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2025 | Gladys | $2.0M Seed | Cornerstone VC | Long Journey Ventures, Exceptional Ventures, Houghton Street Ventures, UFI Ventures |